Deep Genomics
Best for biotech
AI-driven drug discovery
Advanced genomic research
Enterprise solution
RNA therapy focus
Programming RNA Therapies for Any Gene, Any Genetic Condition
Last updated: May 30, 2026
ENTERPRISE
deepgenomics.com
Quick Answer
Deep Genomics is an AI-driven genetic medicine company that programs RNA therapies for various genetic conditions. Its proprietary AI platform analyzes complex RNA biology, identifies novel targets, and evaluates therapeutic candidates. Best for pharmaceutical and biotech companies seeking to accelerate drug discovery. Pricing is enterprise-level.
About Deep Genomics
Deep Genomics provides an AI platform for drug development, leveraging AI, RNA biology, and automation to program RNA therapies. It untangles complex RNA biology, identifies novel targets, and evaluates therapeutic candidates to address genetic conditions. The platform is designed for data-driven prediction and exponential growth in drug discovery.
What Makes It Unique
Deep Genomics developed the first Foundation Model for RNA Biology, BigRNA, and is advancing to BigRNA+ to expand mechanisms and genetic variants for complex disease modulation.
AI-extracted from public sources. May contain errors. Methodology · Are you Deep Genomics? Claim listing